ATE317020T1 - Neues regulationssystem zur kontrolle der expression eines transgens - Google Patents

Neues regulationssystem zur kontrolle der expression eines transgens

Info

Publication number
ATE317020T1
ATE317020T1 AT99971861T AT99971861T ATE317020T1 AT E317020 T1 ATE317020 T1 AT E317020T1 AT 99971861 T AT99971861 T AT 99971861T AT 99971861 T AT99971861 T AT 99971861T AT E317020 T1 ATE317020 T1 AT E317020T1
Authority
AT
Austria
Prior art keywords
controlling
expression
nucleic acid
transgene
regulatory system
Prior art date
Application number
AT99971861T
Other languages
English (en)
Inventor
Jacques Mallet
Olga Corti
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE317020T1 publication Critical patent/ATE317020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
AT99971861T 1998-11-09 1999-11-09 Neues regulationssystem zur kontrolle der expression eines transgens ATE317020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (fr) 1998-11-09 1998-11-09 Nouveau systeme de regulation de l'expression d'un transgene
US12260099P 1999-03-03 1999-03-03

Publications (1)

Publication Number Publication Date
ATE317020T1 true ATE317020T1 (de) 2006-02-15

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971861T ATE317020T1 (de) 1998-11-09 1999-11-09 Neues regulationssystem zur kontrolle der expression eines transgens

Country Status (11)

Country Link
EP (1) EP1129204B1 (de)
JP (1) JP4516215B2 (de)
KR (1) KR20020013476A (de)
CN (1) CN1352694A (de)
AT (1) ATE317020T1 (de)
AU (1) AU1165400A (de)
CA (1) CA2351015C (de)
DE (1) DE69929718T2 (de)
HU (1) HUP0104032A3 (de)
IL (1) IL142761A0 (de)
WO (1) WO2000028062A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
WO2002086131A1 (fr) * 2001-04-09 2002-10-31 Gencom Corporation Unite de regulation de l'expression genetique et utilisation de cette unite
CN1453361A (zh) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 一种抗癌靶向可调控基因－病毒的构建方法
AU2010316996A1 (en) * 2009-11-05 2012-06-14 Proyecto De Biomedicina Cima, S.L. Regulated expression systems
CN102690338A (zh) * 2012-05-25 2012-09-26 中国农业大学 一种与四环素结合的蛋白TetR及其编码基因和应用
CN110358812B (zh) * 2019-06-25 2022-12-27 武汉生物工程学院 一种用于λ-Red重组系统基因敲除重组阳性克隆检测的引物及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029442A2 (en) * 1993-06-14 1994-12-22 Basf Aktiengesellschaft Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
CA2351015A1 (fr) 2000-05-18
JP2002529099A (ja) 2002-09-10
DE69929718T2 (de) 2006-11-09
JP4516215B2 (ja) 2010-08-04
CN1352694A (zh) 2002-06-05
KR20020013476A (ko) 2002-02-20
EP1129204A1 (de) 2001-09-05
DE69929718D1 (de) 2006-04-13
WO2000028062A1 (fr) 2000-05-18
IL142761A0 (en) 2002-03-10
HUP0104032A2 (hu) 2002-02-28
AU1165400A (en) 2000-05-29
EP1129204B1 (de) 2006-02-01
CA2351015C (fr) 2011-09-27
HUP0104032A3 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
MX9800419A (es) Haloperoxidasas de curvularia verruculosa y acidos nucleicos que codifican para los mismos.
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
MY125594A (en) Immortalized cell lines for virus growth
DE69834267D1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
DE69635609D1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
ATE355370T1 (de) Starker homologer promotor aus hamster
SG141233A1 (en) Control of gene expression
IL127897A (en) Hamster ef-1alpha transcriptional regulatory dna
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE60040497D1 (de) Gene, welche für Flavon-Synthasen kodieren
ATE317020T1 (de) Neues regulationssystem zur kontrolle der expression eines transgens
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
HK1038572A1 (en) Growth differentiation factor promoter and uses therefor
WO1999023216A3 (en) Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
AU1896500A (en) High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
AU1054699A (en) Cold-inducible expression vector
AUPM772494A0 (en) Improvements in production of proteins in host cells
WO2003070878A3 (en) Antisense modulation of hematopoietic cell protein tyrosine kinase expression
ATE225852T1 (de) Menschlicher epidermaler gen-promotor
DE50010015D1 (de) Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung
AU6722498A (en) Disubstituted biphenyloxazolines
ES2164907T3 (es) Secuencias reguladoras del gen cd4 y su expresion especifica en los linfocitos t maduros.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties